PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS

Methods for treating breast cancer, specifically cancers resistant to treatment with one or more known breast cancer treatment drugs, and related patient selection strategies for predicting patient response to drug therapy, such strategies including detecting the presence or absence in a patient of...

Full description

Saved in:
Bibliographic Details
Main Authors Johnston, Daniel Stephen, Strahs, Andrew Louis, Feingold, Jay Marshall, Zacharchuk, Charles Michael, Coughlin, Christina Marie, Berkenblit, Anna
Format Patent
LanguageEnglish
Published 05.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods for treating breast cancer, specifically cancers resistant to treatment with one or more known breast cancer treatment drugs, and related patient selection strategies for predicting patient response to drug therapy, such strategies including detecting the presence or absence in a patient of one or more of PIK3CA gene amplification, a mutation in PIK3CA, and a decrease in PTEN protein expression, and treating a patient positive for the presence of one or more of same by administering to the subject a pan-ErbB tyrosine kinase inhibitor.
Bibliography:Application Number: US201916416083